Submitted by J. Grosse on Thu, 06/08/2026 - 11:02
We are delighted to announce that from April 2027 we will be hosting the University of Cambridge element of the MRC Centre of Research Excellence in Mitochondrial Genome Therapeutics (CoRE-MitoGT).
Funded by the Medical Research Council, CoRE-MitoGT brings together world-leading experts in mitochondrial disease, genome engineering, and clinical translation from across the UK and beyond, with the clear goal of improving patient outcomes for devastating mitochondrial DNA diseases.
This global initiative will be led by Michal Minczuk in Cambridge and will be supported by experts from University of Cambridge, University of Birmingham, The University of Manchester, Heidelberg University, Institut Imagine, The University of Queensland. Additional support comes from national investment and research initiatives, patient advocacy, and includes biotechnology and venture capital investment.
We look forward to seeing the exciting developments that the team will deliver including the transformative mitochondrial therapeutics which will offer hope to patients and families.
Images acquired at the MBU-Light Microscopy Facility using cells generated in Dr. Julien Prudent's lab and acquired by Dr. Roy Chowdhury.